MUC1 and breast cancer: These nanoparticles were instrumental in developing a unique electrode modification, facilitating the creation of a sensitive impedimetric immunosensor capable of quantitatively detecting canine mammary tumor biomarkers, specifically CA 15–3 and MUC-1, in serum and tissue homogenate samples.